140
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Identification of Anomalous Features of Intravitreal Injections Using Micro-Computed Tomography

, , &
Pages 375-380 | Received 16 Jun 2011, Accepted 23 Oct 2012, Published online: 18 Dec 2012

REFERENCES

  • Hubschman JP, Coffee RE, Bourges JL, Yu F, Schwartz SD. Experimental model of intravitreal injection techniques. Retina (Philadelphia, Pa) 2010;30:167–173.
  • Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina (Philadelphia, Pa) 2004;24:676–698.
  • Somner JE, Mansfield D. Inadvertent injection of intravitreal air during intravitreal Lucentis injection for wet age-related macular degeneration: an undescribed complication. Eye (Lond) 2009;23:1744.
  • Freund KB, Laud K, Eandi CM, Spaide RF. Silicone oil droplets following intravitreal injection. Retina (Philadelphia, Pa) 2006;26:701–703.
  • Bakri SJ, Ekdawi NS. Intravitreal silicone oil droplets after intravitreal drug injections. Retina (Philadelphia, Pa) 2008;28:996–1001.
  • Lee B, Litt M, Buchsbaum G. Rheology of the vitreous body. Part I: Viscoelasticity of human vitreous. Biorheology 1992;29:521–533.
  • Lee B, Litt M, Buchsbaum G. Rheology of the vitreous body: part 3. Concentration of electrolytes, collagen and hyaluronic acid. Biorheology 1994;31:339–351.
  • Tan LE, Orilla W, Hughes PM, Tsai S, Burke JA, Wilson CG. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles. Invest Ophthalmol Vis Sci 2011;52:1111–1118.
  • Maurice D. Review: practical issues in intravitreal drug delivery. J Ocul Pharmacol Ther 2001;17:393–401.
  • Li SK, Jeong EK, Hastings MS. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis. Invest Ophthalmol Vis Sci 2004;45:1224–1231.
  • Park J, Bungay PM, Lutz RJ, Augsburger JJ, Millard RW, Sinha Roy A et al. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. J Control Release 2005;105:279–295.
  • Friedrich S, Cheng YL, Saville B. Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume. Curr Eye Res 1997;16:663–669.
  • Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006;79:248–253.
  • CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364(20):1897–1908.
  • Thompson JT. Kinetics of intraocular gases. Disappearance of air, sulfur hexafluoride, and perfluoropropane after pars plana vitrectomy. Arch Ophthalmol 1989;107:687–691.
  • Markus H, Loh A, Israel D, Buckenham T, Clifton A, Brown MM. Microscopic air embolism during cerebral angiography and strategies for its avoidance. Lancet 1993;341:784–787.
  • Bove AA, Gimenez JL. Computer analysis of flow characteristics of injection catheters. Invest Radiol 1968;3:427–432.
  • Meltzer RS, Tickner EG, Sahines TP, Popp RL. The source of ultrasound contrast effect. J Clin Ultrasound 1980;8:121–127.
  • Mishra C, Peles Y. Cavitation in flow through a micro-orifice inside a silicon microchannel. Physics of Fluids 2005;17:013601–013615.
  • Simpkins PG, Kuck VJ. On air entrainment in coatings. J Colloid Interface Sci 2003;263:562–571.
  • Wagner A. Advances in prefilled syringe technology. Innovations in pharmaceutical technology. London: Samedan Ltd; 2008.
  • Liu L, Ammar DA, Ross LA, Mandava N, Kahook MY, Carpenter JF. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling. Invest Ophthalmol Vis Sci 2011;52:1023–1034.
  • Foster WJ. Vitreous Substitutes. Expert Rev Ophthalmol 2008;3:211–218.
  • Zimberlin JA, Sanabria-DeLong N, Tew GN, Crosby AJ. Cavitation rheology for soft materials. Soft Matter 2007;3:763–767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.